LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 3 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 3. - Dataset (ID:20311)

Filter results: >>>>
Cell Small Molecule Small Mol Concentration (uM) Time Point (hr) Total Cell Count Before Treatment Total Cell Count After Treatment Total Control Cell Count Relative Cell Count Normalized Growth Rate Inhibition Value Assay Plate Assay Well
MCF 10A-H2B-mCherry Neratinib
0.1
56.45 27.76 250 5745 0.0435 0.3307
MN20160318_Q01
F14
MCF 10A-H2B-mCherry Neratinib
0.1
56.45 27.76 1997 5745 0.3476 0.7433
MN20160318_Q01
F14
MCF 10A-H2B-mCherry Neratinib
0.1
56.45 27.76 2502 5745 0.4355 0.7952
MN20160318_Q01
N05
MCF 10A-H2B-mCherry Neratinib
0.1
56.45 27.76 2516 5745 0.4379 0.7965
MN20160318_Q01
N05
MCF 10A-H2B-mCherry Neratinib
0.1
58.15 27.76 2041 5906 0.3455 0.7432
MN20160318_Q01
D18
MCF 10A-H2B-mCherry Neratinib
0.1
58.15 27.76 2083 5906 0.3527 0.7478
MN20160318_Q01
D18
MCF 10A-H2B-mCherry Neratinib
0.1
58.15 27.76 282 5906 0.0477 0.3496
MN20160318_Q01
F14
MCF 10A-H2B-mCherry Neratinib
0.1
58.15 27.76 2151 5906 0.3642 0.7551
MN20160318_Q01
F14
MCF 10A-H2B-mCherry Neratinib
0.1
58.15 27.76 2637 5906 0.4465 0.8019
MN20160318_Q01
N05
MCF 10A-H2B-mCherry Neratinib
0.1
58.15 27.76 2653 5906 0.4492 0.8034
MN20160318_Q01
N05
MCF 10A-H2B-mCherry Neratinib
0.1
59.85 27.76 2193 6062 0.3617 0.7547
MN20160318_Q01
D18
MCF 10A-H2B-mCherry Neratinib
0.1
59.85 27.76 2232 6062 0.3682 0.7587
MN20160318_Q01
D18
MCF 10A-H2B-mCherry Neratinib
0.1
59.85 27.76 318 6062 0.0525 0.3686
MN20160318_Q01
F14
MCF 10A-H2B-mCherry Neratinib
0.1
59.85 27.76 2241 6062 0.3696 0.7596
MN20160318_Q01
F14
MCF 10A-H2B-mCherry Neratinib
0.1
59.85 27.76 2813 6062 0.4640 0.8118
MN20160318_Q01
N05
MCF 10A-H2B-mCherry Neratinib
0.1
59.85 27.76 2825 6062 0.4660 0.8128
MN20160318_Q01
N05
MCF 10A-H2B-mCherry Neratinib
0.1
61.56 27.76 2157 6217 0.3469 0.7464
MN20160318_Q01
D18
MCF 10A-H2B-mCherry Neratinib
0.1
61.56 27.76 2195 6217 0.3531 0.7503
MN20160318_Q01
D18
MCF 10A-H2B-mCherry Neratinib
0.1
61.56 27.76 338 6217 0.0544 0.3773
MN20160318_Q01
F14
MCF 10A-H2B-mCherry Neratinib
0.1
61.56 27.76 2329 6217 0.3746 0.7636
MN20160318_Q01
F14
MCF 10A-H2B-mCherry Neratinib
0.1
61.56 27.76 2935 6217 0.4721 0.8167
MN20160318_Q01
N05
MCF 10A-H2B-mCherry Neratinib
0.1
61.56 27.76 2955 6217 0.4753 0.8183
MN20160318_Q01
N05
MCF 10A-H2B-mCherry Neratinib
0.1
63.26 27.76 2377 6465 0.3676 0.7610
MN20160318_Q01
D18
MCF 10A-H2B-mCherry Neratinib
0.1
63.26 27.76 2417 6465 0.3738 0.7648
MN20160318_Q01
D18
MCF 10A-H2B-mCherry Neratinib
0.1
63.26 27.76 350 6465 0.0541 0.3803
MN20160318_Q01
F14